Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR

References

• Swanepoel R, Coetzer JAW. Rift Valley fever. In: Infectious diseases of livestock with special reference to southern Africa. 2nd ed. Coetzer JAW and Tustin RC, editors. Oxford University Press: Cape Town, South Africa, 2004; pp.1037-1070.
   Google Scholar
• Ikegami T, Makino S. The pathogenesis of rift valley fever. Viruses 2011; 3:493-519; PMID:21666766; http://dx.doi.org/10.3390/v3050493
   PubMed Web of Science ®Google Scholar
• Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 2010; 41:61; PMID:21188836
   PubMed Web of Science ®Google Scholar
• Dar O, Hogarth S, McIntyre S. Tempering the risk: Rift Valley fever and bioterrorism. Trop Med Int Health 2013; 18:1036-41; PMID:23527825; http://dx.doi.org/10.1111/tmi.12108
   PubMed Web of Science ®Google Scholar
• Jonsson CB, Cole KS, Roy CJ, Perlin DS, Byrne G. Challenges and practices in building and implementing biosafety and biosecurity programs to enable basic and translational research with select agents. J Bioterror Biodef 2013; Suppl 3:12634; PMID:24900945
   PubMedGoogle Scholar
• Shurtleff AC, Garza N, Lackemeyer M, Carrion R, Jr., Griffiths A, Patterson J, Edwin SS, Bavari S. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses 2012; 4:3932-51; PMID:23342380
   PubMed Web of Science ®Google Scholar
• Schmaljohn C, Nichol ST. Bunyaviridae. In Fields Virology, 5th ed Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus, editors. Lippincott, Williams & Wilkins: Philadelphia, PA 2007; pp.1741-89.
   Google Scholar
• Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004; 116:541-50; PMID:14980221
   PubMed Web of Science ®Google Scholar
• Kalveram B, Lihoradova O, Ikegami T. NSs protein of rift valley fever virus promotes post-translational downregulation of the TFIIH subunit p62. J Virol 2011; 85:6234-43; PMID:21543505; http://dx.doi.org/10.1128/JVI.02255-10
   PubMed Web of Science ®Google Scholar
• Kainulainen M, Habjan M, Hubel P, Busch L, Lau S, Colinge J, Superti-Furga G, Pichlmair A, Weber F. Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol 2014; 88:3464-73; PMID:24403578; http://dx.doi.org/10.1128/JVI.02914-13
   PubMed Web of Science ®Google Scholar
• Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004; 78:9798-806; PMID:15331713
   PubMed Web of Science ®Google Scholar
• Le May N, Mansuroglu Z, Leger P, Josse T, Blot G, Billecocq A, Flick R, Jacob Y, Bonnefoy E, Bouloy M. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 2008; 4:e13; PMID:18225953; http://dx.doi.org/10.1371/journal.ppat.0040013
   PubMed Web of Science ®Google Scholar
• Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009; 5:e1000287; PMID:19197350; http://dx.doi.org/10.1371/journal.ppat.1000287
   PubMed Web of Science ®Google Scholar
• Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009; 83:4365-75; PMID:19211744; http://dx.doi.org/10.1128/JVI.02148-08
   PubMed Web of Science ®Google Scholar
• Mudhasani R, Tran JP, Retterer C, Kota KP, Whitehouse CA, Bavari S. Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase. PLoS Pathog 2016; 12:e1005437; PMID:26837067; http://dx.doi.org/10.1371/journal.ppat.1005437
   PubMedGoogle Scholar
• Ikegami T, Makino S. Rift valley fever vaccines. Vaccine 2009; 27 Suppl 4:D69-72; PMID:19837291; http://dx.doi.org/10.1016/j.vaccine.2009.07.046
   PubMedGoogle Scholar
• Botros B, Omar A, Elian K, Mohamed G, Soliman A, Salib A, Salman D, Saad M, Earhart K. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J Med Virol 2006; 78:787-91; PMID:16628582
   PubMed Web of Science ®Google Scholar
• Grobbelaar AA, Weyer J, Leman PA, Kemp A, Paweska JT, Swanepoel R. Molecular epidemiology of Rift Valley fever virus. Emerg Infect Dis 2011; 17:2270-6; PMID:22172568; http://dx.doi.org/10.3201/eid1712.111035
   PubMed Web of Science ®Google Scholar
• Miller MM, Bennett KE, Drolet BS, Lindsay R, Mecham JO, Reeves WK, Weingartl HM, Wilson WC. Evaluation of the efficacy, potential for vector transmission, and duration of immunity of MP-12, an attenuated Rift Valley fever virus vaccine candidate, in sheep. Clin Vaccine Immunol 2015; 22:930-7; PMID:26041042; http://dx.doi.org/10.1128/CVI.00114-15
   PubMed Web of Science ®Google Scholar
• Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN. Rift valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and L segments. J Virol 2015; 89:7262-76; PMID:25948740; http://dx.doi.org/10.1128/JVI.00135-15
   PubMed Web of Science ®Google Scholar
• Nishiyama S, Lokugamage N, Ikegami T. The L-, M- and S-segments of Rift Valley fever virus MP-12 vaccine independently contribute to a temperature-sensitive phenotype. J Virol 2016; 90:3735-44; PMID:26819307; http://dx.doi.org/10.1128/JVI.02241-15
   PubMed Web of Science ®Google Scholar
• Lihoradova O, Ikegami T. Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever. Expert Rev Vaccines 2012; 11:1283-5; PMID:23249225; http://dx.doi.org/10.1586/erv.12.106
   PubMed Web of Science ®Google Scholar
• Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001; 75:1371-7; PMID:11152510
   PubMed Web of Science ®Google Scholar
• Ikegami T, Won S, Peters CJ, Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 2006; 80:2933-40; PMID:16501102
   PubMed Web of Science ®Google Scholar
• Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, Hill TE, Tseng CT, Gong B, Fukushi S, Morikawa S, et al. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. J Virol 2012; 86:7650-61; PMID:22573861; http://dx.doi.org/10.1128/JVI.00778-12
   PubMed Web of Science ®Google Scholar
• Morrill JC, Laughlin RC, Lokugamage N, Pugh R, Sbrana E, Weise WJ, Adams LG, Makino S, Peters CJ. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine 2013; 31:559-65; PMID:23153443; http://dx.doi.org/10.1016/j.vaccine.2012.10.118
   PubMed Web of Science ®Google Scholar
• Morrill JC, Laughlin RC, Lokugamage N, Wu J, Pugh R, Kanani P, Adams LG, Makino S, Peters CJ. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine 2013; 31:4988-94; PMID:23994375; http://dx.doi.org/10.1016/j.vaccine.2013.08.003
   PubMed Web of Science ®Google Scholar
• Gori Savellini G, Weber F, Terrosi C, Habjan M, Martorelli B, Cusi MG. Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol 2010; 92:71-9; PMID:20861320; http://dx.doi.org/10.1099/vir.0.025999-0
   PubMed Web of Science ®Google Scholar
• Gori-Savellini G, Valentini M, Cusi MG. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013; 87:6660-7; PMID:23552410; http://dx.doi.org/10.1128/JVI.03129-12
   PubMed Web of Science ®Google Scholar
• Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T. Characterization of Rift Valley Fever Virus MP-12 Strain Encoding NSs of Punta Toro Virus or Sandfly Fever Sicilian Virus. PLoS Negl Trop Dis 2013; 7:e2181; PMID:23638202; http://dx.doi.org/10.1371/journal.pntd.0002181
   PubMed Web of Science ®Google Scholar
• Perrone LA, Narayanan K, Worthy M, Peters CJ. The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol 2007; 81:884-92; PMID:17050607
   PubMed Web of Science ®Google Scholar
• Kalveram B, Ikegami T. Toscana Virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase. J Virol 2013; 87:3710-8; PMID:23325696; http://dx.doi.org/10.1128/JVI.02506-12
   PubMed Web of Science ®Google Scholar
• Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, et al. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice. J Gen Virol 2013; 94:1441-50; PMID:23515022; http://dx.doi.org/10.1099/vir.0.051250-0
   PubMed Web of Science ®Google Scholar
• Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007; 89:799-811; PMID:17451862
   PubMed Web of Science ®Google Scholar
• Li S, Koromilas AE. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J Biol Chem 2001; 276:13881-90; PMID:11278390
   PubMed Web of Science ®Google Scholar
• Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE. The pathogenesis of Rift Valley fever virus in the mouse model. Virology 2010; 407:256-67; PMID:20850165; http://dx.doi.org/10.1016/j.virol.2010.08.016
   PubMed Web of Science ®Google Scholar
• Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, Smith J, Bouloy M. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 1995; 53:405-11; PMID:7485695
   PubMed Web of Science ®Google Scholar
• Dodd KA, McElroy AK, Jones TL, Zaki SR, Nichol ST, Spiropoulou CF. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model. PLoS Negl Trop Dis 2014; 8:e2874; PMID:24922480; http://dx.doi.org/10.1371/journal.pntd.0002874
   PubMed Web of Science ®Google Scholar
• Pifat DY, Smith JF. Punta Toro virus infection of C57BL/6J mice: a model for phlebovirus-induced disease. Microb Pathog 1987; 3:409-22; PMID:2462155
   PubMed Web of Science ®Google Scholar
• Gowen BB, Wong MH, Jung KH, Sanders AB, Mitchell WM, Alexopoulou L, Flavell RA, Sidwell RW. TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules. J Immunol 2007; 178:5200-8; PMID:17404303
   PubMed Web of Science ®Google Scholar
• Fisher AF, Tesh RB, Tonry J, Guzman H, Liu D, Xiao SY. Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. Am J Trop Med Hyg 2003; 69:269-76; PMID:14628943
   PubMed Web of Science ®Google Scholar
• Bird BH, Albarino CG, Nichol ST. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 2007; 362:10-5; PMID:17412386
   PubMed Web of Science ®Google Scholar
• Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 2003; 47:613-7; PMID:14524622
   PubMed Web of Science ®Google Scholar
• Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, Terasaki K, Zamoto-Niikura A, Peters CJ, Makino S. Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS ONE 2010; 5:e9986; PMID:20376320; http://dx.doi.org/10.1371/journal.pone.0009986
   PubMedGoogle Scholar
• Kalveram B, Lihoradova O, Indran SV, Ikegami T. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp 2011:(57), e3400; PMID:22083261; http://dx.doi.org/10.3791/3400
   PubMedGoogle Scholar